Grants and Contributions:
Title:
Japan Expansion/European Market Research
Agreement Number:
921142
Agreement Value:
$42,325.00
Agreement Date:
Jan 27, 2019 - Oct 31, 2019
Description:
We export drugs through Canadian pharmaceutical firms, PHARMASCIENCE, BIOLYSE PHARMA, LERNA PHARMA and lOMÉGA Ltée, to the Ivory Coast and Senegal, and diversify our operations in Cameroon.
Organization:
National Research Council Canada
Expected Results:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Edmonton, Alberta, CA T6E 5E8
Reference Number:
172-2018-2019-Q4-921142
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
858862766
Recipient Type:
For-profit organization
Recipient's Legal Name:
Convenient Business Solutions Inc.
Federal Riding Name:
Edmonton Strathcona
Federal Riding Number:
48019
Program:
CanExport
Program Purpose:
CanExport is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
541990